These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 38803689)

  • 1. Significance of Pre-Treatment CALLY Score Combined with EBV-DNA Levels for Prognostication in Non-Metastatic Nasopharyngeal Cancer Patients: A Clinical Perspective.
    Jiang T; Sun H; Xu T; Xue S; Xia W; Xiao X; Wang Y; Guo L; Lin H
    J Inflamm Res; 2024; 17():3353-3369. PubMed ID: 38803689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic nomogram for patients with Nasopharyngeal Carcinoma incorporating hematological biomarkers and clinical characteristics.
    Li J; Chen S; Peng S; Liu Y; Xing S; He X; Chen H
    Int J Biol Sci; 2018; 14(5):549-556. PubMed ID: 29805306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Superiority of CRP-albumin-lymphocyte index as a prognostic biomarker for patients with gastric cancer.
    Zhang H; Shi J; Xie H; Liu X; Ruan G; Lin S; Ge Y; Liu C; Chen Y; Zheng X; Song M; Yang M; Zhang X; Shi HP
    Nutrition; 2023 Dec; 116():112191. PubMed ID: 37716090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nomogram incorporating Epstein-Barr virus DNA and a novel immune-nutritional marker for survival prediction in nasopharyngeal carcinoma.
    Wu S; Yuan X; Huang H; Li Y; Cui L; Lin D; Lu W; Feng H; Chen Z; Liu X; Tan J; Wang F
    BMC Cancer; 2023 Dec; 23(1):1217. PubMed ID: 38066499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic values of the integrated model incorporating the volume of metastatic regional cervical lymph node and pretreatment serum Epstein-Barr virus DNA copy number in predicting distant metastasis in patients with N1 nasopharyngeal carcinoma.
    Yao JJ; Zhou GQ; Wang YQ; Wang SY; Zhang WJ; Jin YN; Zhang F; Li L; Liu LZ; Cheng ZB; Ma J; Qi ZY; Sun Y
    Chin J Cancer; 2017 Dec; 36(1):98. PubMed ID: 29284539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrating Postradiotherapy MRI-Detected Lymph Node Necrosis and Pre- and Posttreatment Epstein-Barr Virus-DNA for Risk Stratification in Nasopharyngeal Carcinoma.
    Cao D; Li S; Li H; Liu L; Wang X; Quan T
    J Magn Reson Imaging; 2023 Jul; 58(1):108-119. PubMed ID: 36326089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic efficacy of the combination of the pretreatment systemic Immune-Inflammation Index and Epstein-Barr virus DNA status in locally advanced Nasopharyngeal Carcinoma Patients.
    Xiong Y; Shi LL; Zhu LS; Ding Q; Ba L; Peng G
    J Cancer; 2021; 12(8):2275-2284. PubMed ID: 33758605
    [No Abstract]   [Full Text] [Related]  

  • 8. Establishment and Validation of Nomogram Based on Combination of Pretreatment C-Reactive Protein/Albumin Ratio-EBV DNA Grade in Nasopharyngeal Carcinoma Patients Who Received Concurrent Chemoradiotherapy.
    Huang ZZ; Wen W; Hua X; Song CG; Bi XW; Huang JJ; Xia W; Yuan ZY
    Front Oncol; 2021; 11():583283. PubMed ID: 34336633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A nomogram based on nutritional and inflammatory parameters to predict DMFS and identify beneficiaries of adjuvant chemotherapy in IVA-stage nasopharyngeal carcinoma.
    Pan Y; Chen Z; Hong W; Huang Z; Li Y; Cai S; Lai J; Lu J; Qiu S
    BMC Cancer; 2024 May; 24(1):578. PubMed ID: 38734620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel prognostic model predicts overall survival in patients with nasopharyngeal carcinoma based on clinical features and blood biomarkers.
    Lai C; Zhang C; Lv H; Huang H; Ke X; Zhou C; Chen H; Chen S; Zhou L
    Cancer Med; 2021 Jun; 10(11):3511-3523. PubMed ID: 33973727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a Nomogram Model for Treatment of Nonmetastatic Nasopharyngeal Carcinoma.
    Zhang LL; Xu F; Song D; Huang MY; Huang YS; Deng QL; Li YY; Shao JY
    JAMA Netw Open; 2020 Dec; 3(12):e2029882. PubMed ID: 33306119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The value of CRP-albumin-lymphocyte index (CALLY index) as a prognostic biomarker in patients with non-small cell lung cancer.
    Liu XY; Zhang X; Zhang Q; Ruan GT; Liu T; Xie HL; Ge YZ; Song MM; Deng L; Shi HP
    Support Care Cancer; 2023 Aug; 31(9):533. PubMed ID: 37610445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nasopharyngeal necrosis contributes to overall survival in nasopharyngeal carcinoma without distant metastasis: a comprehensive nomogram model.
    Sun XS; Xiao ZW; Liu SL; Sun R; Luo DH; Chen QY; Mai HQ
    Eur Radiol; 2023 May; 33(5):3682-3692. PubMed ID: 36735041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional lymph node density-based nomogram predicts prognosis in nasopharyngeal carcinoma patients without distant metastases.
    Ma J; Zhao R; Wu YL; Liu Y; Jin GQ; Su DK
    Cancer Imaging; 2023 Dec; 23(1):123. PubMed ID: 38102725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of EBV DNA and platelet-to-lymphocyte ratio in patients with non-metastatic nasopharyngeal carcinoma: a retrospective study.
    Dong H; Huang Z; Yang D; Li Z; Huang H; Meng Z; Qin Y; Kang M
    BMC Cancer; 2023 Jul; 23(1):673. PubMed ID: 37464319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of pan-immune-inflammation value (PIV) in nasopharyngeal carcinoma patients.
    Zhang N; Hou T; Zhang S; Ling J; Jiang S; Xie Y; Liu X; Hu C; Feng Y
    Heliyon; 2024 Jan; 10(2):e24804. PubMed ID: 38312571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Value of Plasma Epstein-Barr Virus DNA Levels Pre- and Post-Neoadjuvant Chemotherapy in Patients With Nasopharyngeal Carcinoma.
    Zhu L; Ouyang T; Xiong Y; Ba L; Li Q; Qiu M; Zou Z; Peng G
    Front Oncol; 2021; 11():714433. PubMed ID: 34707987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The diagnostic and prognostic values of plasma Epstein-Barr virus DNA for residual cervical lymphadenopathy in nasopharyngeal carcinoma patients: a retrospective study.
    Liu SL; Sun XS; Li XY; Tang LQ; Chen QY; Lin HX; Liang YJ; Yan JJ; Lin C; Guo SS; Liu LT; Li Y; Xie HJ; Tang QN; Liang H; Guo L; Mai HQ
    Cancer Commun (Lond); 2019 Mar; 39(1):14. PubMed ID: 30925939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of Survival Model Performance Following Inclusion of Epstein-Barr Virus DNA Status in Conventional TNM Staging Groups in Epstein-Barr Virus-Related Nasopharyngeal Carcinoma.
    Li WZ; Wu HJ; Lv SH; Hu XF; Liang H; Liu GY; Lu N; Bei WX; Lv X; Guo X; Xia WX; Xiang YQ
    JAMA Netw Open; 2021 Sep; 4(9):e2124721. PubMed ID: 34554238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of AKR1C4 and the advantage of combining EBV DNA to stratify patients at high risk of locoregional recurrence of nasopharyngeal carcinoma.
    Guo SS; Chen YZ; Liu LT; Liu RP; Liang YJ; Wen DX; Jin J; Tang LQ; Mai HQ; Chen QY
    BMC Cancer; 2022 Aug; 22(1):880. PubMed ID: 35953777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.